Selected research
Industry Research
Ramipril Industry Research Report 2026
Market perspective
The global Ramipril market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ramipril is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ramipril is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Ramipril is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ramipril include Novartis, King Pharmaceuticals, Westfield Pharma, Santa Cruz Biotechnology, Sanofi-Aventis, Pharmanova, Opsonin Pharma Limited., Lek and Krka, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ramipril market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ramipril Market by Company
Novartis
King Pharmaceuticals
Westfield Pharma
Santa Cruz Biotechnology
Sanofi-Aventis
Pharmanova
Opsonin Pharma Limited.
Lek
Krka
Hemofarm
Cemelog-BRS
Arrow Pharmaceuticals
Ramipril Segment by Type
Tablet Ramipril
Capsule Ramipril
Ramipril Segment by Application
Clinic
Hospital
Others
Ramipril Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ramipril market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ramipril and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ramipril.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ramipril manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ramipril by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ramipril in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet Ramipril
- Capsule Ramipril
Applications
- Clinic
- Hospital
- Others
Companies covered
- Novartis
- King Pharmaceuticals
- Westfield Pharma
- Santa Cruz Biotechnology
- Sanofi-Aventis
- Pharmanova
- Opsonin Pharma Limited.
- Lek
- Krka
- Hemofarm
- Cemelog-BRS
- Arrow Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Ramipril Market Size (2021-2032)
- 2.2.2 Global Ramipril Sales (2021-2032)
- 2.2.3 Global Ramipril Market Average Price (2021-2032)
- 2.3 Ramipril by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablet Ramipril
- 2.3.3 Capsule Ramipril
- 2.4 Ramipril by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinic
- 2.4.3 Hospital
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ramipril Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Ramipril Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Ramipril Revenue of Manufacturers (2021-2026)
- 3.4 Global Ramipril Average Price by Manufacturers (2021-2026)
- 3.5 Global Ramipril Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Ramipril, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Ramipril, Product Type & Application
- 3.8 Global Manufacturers of Ramipril, Established Date
- 3.9 Global Ramipril Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis
- 4.1.1 Novartis Company Information
- 4.1.2 Novartis Business Overview
- 4.1.3 Novartis Ramipril Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis Ramipril Product Portfolio
- 4.1.5 Novartis Recent Developments
- 4.2 King Pharmaceuticals
- 4.2.1 King Pharmaceuticals Company Information
- 4.2.2 King Pharmaceuticals Business Overview
- 4.2.3 King Pharmaceuticals Ramipril Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 King Pharmaceuticals Ramipril Product Portfolio
- 4.2.5 King Pharmaceuticals Recent Developments
- 4.3 Westfield Pharma
- 4.3.1 Westfield Pharma Company Information
- 4.3.2 Westfield Pharma Business Overview
- 4.3.3 Westfield Pharma Ramipril Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Westfield Pharma Ramipril Product Portfolio
- 4.3.5 Westfield Pharma Recent Developments
- 4.4 Santa Cruz Biotechnology
- 4.4.1 Santa Cruz Biotechnology Company Information
- 4.4.2 Santa Cruz Biotechnology Business Overview
- 4.4.3 Santa Cruz Biotechnology Ramipril Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Santa Cruz Biotechnology Ramipril Product Portfolio
- 4.4.5 Santa Cruz Biotechnology Recent Developments
- 4.5 Sanofi-Aventis
- 4.5.1 Sanofi-Aventis Company Information
- 4.5.2 Sanofi-Aventis Business Overview
- 4.5.3 Sanofi-Aventis Ramipril Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sanofi-Aventis Ramipril Product Portfolio
- 4.5.5 Sanofi-Aventis Recent Developments
- 4.6 Pharmanova
- 4.6.1 Pharmanova Company Information
- 4.6.2 Pharmanova Business Overview
- 4.6.3 Pharmanova Ramipril Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pharmanova Ramipril Product Portfolio
- 4.6.5 Pharmanova Recent Developments
- 4.7 Opsonin Pharma Limited.
- 4.7.1 Opsonin Pharma Limited. Company Information
- 4.7.2 Opsonin Pharma Limited. Business Overview
- 4.7.3 Opsonin Pharma Limited. Ramipril Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Opsonin Pharma Limited. Ramipril Product Portfolio
- 4.7.5 Opsonin Pharma Limited. Recent Developments
- 4.8 Lek
- 4.8.1 Lek Company Information
- 4.8.2 Lek Business Overview
- 4.8.3 Lek Ramipril Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lek Ramipril Product Portfolio
- 4.8.5 Lek Recent Developments
- 4.9 Krka
- 4.9.1 Krka Company Information
- 4.9.2 Krka Business Overview
- 4.9.3 Krka Ramipril Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Krka Ramipril Product Portfolio
- 4.9.5 Krka Recent Developments
- 4.10 Hemofarm
- 4.10.1 Hemofarm Company Information
- 4.10.2 Hemofarm Business Overview
- 4.10.3 Hemofarm Ramipril Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Hemofarm Ramipril Product Portfolio
- 4.10.5 Hemofarm Recent Developments
- 4.11 Cemelog-BRS
- 4.11.1 Cemelog-BRS Company Information
- 4.11.2 Cemelog-BRS Business Overview
- 4.11.3 Cemelog-BRS Ramipril Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Cemelog-BRS Ramipril Product Portfolio
- 4.11.5 Cemelog-BRS Recent Developments
- 4.12 Arrow Pharmaceuticals
- 4.12.1 Arrow Pharmaceuticals Company Information
- 4.12.2 Arrow Pharmaceuticals Business Overview
- 4.12.3 Arrow Pharmaceuticals Ramipril Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Arrow Pharmaceuticals Ramipril Product Portfolio
- 4.12.5 Arrow Pharmaceuticals Recent Developments
5 Global Ramipril Market Scenario by Region
- 5.1 Global Ramipril Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ramipril Sales by Region: 2021-2032
- 5.2.1 Global Ramipril Sales by Region: 2021-2026
- 5.2.2 Global Ramipril Sales by Region: 2027-2032
- 5.3 Global Ramipril Revenue by Region: 2021-2032
- 5.3.1 Global Ramipril Revenue by Region: 2021-2026
- 5.3.2 Global Ramipril Revenue by Region: 2027-2032
- 5.4 North America Ramipril Market Facts & Figures by Country
- 5.4.1 North America Ramipril Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Ramipril Sales by Country (2021-2032)
- 5.4.3 North America Ramipril Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Ramipril Market Facts & Figures by Country
- 5.5.1 Europe Ramipril Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Ramipril Sales by Country (2021-2032)
- 5.5.3 Europe Ramipril Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Ramipril Market Facts & Figures by Country
- 5.6.1 Asia Pacific Ramipril Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Ramipril Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Ramipril Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Ramipril Market Facts & Figures by Country
- 5.7.1 South America Ramipril Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Ramipril Sales by Country (2021-2032)
- 5.7.3 South America Ramipril Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Ramipril Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Ramipril Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Ramipril Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Ramipril Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Ramipril Sales by Type (2021-2032)
- 6.1.1 Global Ramipril Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Ramipril Sales Market Share by Type (2021-2032)
- 6.2 Global Ramipril Revenue by Type (2021-2032)
- 6.2.1 Global Ramipril Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Ramipril Revenue Market Share by Type (2021-2032)
- 6.3 Global Ramipril Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Ramipril Sales by Application (2021-2032)
- 7.1.1 Global Ramipril Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Ramipril Sales Market Share by Application (2021-2032)
- 7.2 Global Ramipril Revenue by Application (2021-2032)
- 7.2.1 Global Ramipril Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Ramipril Revenue Market Share by Application (2021-2032)
- 7.3 Global Ramipril Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Ramipril Value Chain Analysis
- 8.1.1 Ramipril Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Ramipril Production Mode & Process
- 8.2 Ramipril Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Ramipril Distributors
- 8.2.3 Ramipril Customers
9 Global Ramipril Analyzing Market Dynamics
- 9.1 Ramipril Industry Trends
- 9.2 Ramipril Industry Drivers
- 9.3 Ramipril Industry Opportunities and Challenges
- 9.4 Ramipril Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst